Bashir Ahmad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bashir Ahmad has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Jun Lu
Department of Paediatrics, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
4 shared publications - Abduh Murshed3 shared publications
Azizullah Azizullah
Department of Biology, The University of Haripur, Haripur 22620, Khyber Pakhtunkhwa, Pakistan
3 shared publicationsImran Khan
Department of Food Science and Technology, The University of Haripur, Haripur 22620, Khyber Pakhtunkhwa, Pakistan
3 shared publicationsKhalid Ahmad
Affiliation Department of Environmental Sciences, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, KPK Pakistan
3 shared publicationsMohamed Y. Zaky
Affiliation Molecular Physiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Food Quality
- Vol. 2026 (1)
Phytochemical and Pharmacological Insights Into Ranunculus hirtellus Royle: An Animal’s Fodder Plant
Background: Ranunculus hirtellus Royle, a perennial herb belonging to the Ranunculaceae family, is native to the Himalayan region and widely used in traditional medicine. The plant is valued for its diverse applications as an anthelmintic, cooling agent, wound healer, livestock feed, and for managing gout, reproductive disorders, and skin conditions. Despite its considerable ethnobotanical importance, a comprehensive review of its traditional uses and pharmacological properties is still lacking. Aim of the Study: This study aims to systematically review the available literature on the ethnobotanical, phytochemical, and pharmacological properties of R . hirtellus , thereby providing a foundation for future pharmacological and experimental research. Materials and Methods: A comprehensive literature search was conducted using databases such as Google Scholar and PubMed to identify studies related to the ethnobotanical, phytochemical, and pharmacological aspects of R . hirtellus . The review focused on its traditional uses, bioactive compounds, and experimentally validated biological activities. Results: R . hirtellus contains various phytochemicals, including flavonoids, steroids, glycosides, quinones, lactones, and lignified fibers. It exhibits diverse pharmacological activities, including antioxidant, antidiabetic, antibacterial, antifungal, anthelmintic, antiaging, antigout, anti‐irritant, and wound healing properties. In addition, it is used as livestock feed, a cooling agent, and for treating reproductive disorders. Preliminary evidence suggests its potential for anticancer, anti‐inflammatory, neuroprotective, and antiasthmatic effects, which remain underexplored. Conclusion: This review consolidates the traditional and pharmacological knowledge of R . hirtellus , highlighting its biomedical potential. Further computational and experimental studies are warranted to validate its therapeutic properties and explore its unexplored pharmacological activities.
- 1 January 2026
- Published by Wiley in Journal of Food Quality
- Vol. 2026 (1)
Open AccessPhytochemical and Pharmacological Insights Into Ranunculus hirtellus Royle: An Animal’s Fodder Plant
Background: Ranunculus hirtellus Royle, a perennial herb belonging to the Ranunculaceae family, is native to the Himalayan region and widely used in traditional medicine. The plant is valued for its diverse applications as an anthelmintic, cooling agent, wound healer, livestock feed, and for managing gout, reproductive disorders, and skin conditions. Despite its considerable ethnobotanical importance, a comprehensive review of its traditional uses and pharmacological properties is still lacking. Aim of the Study: This study aims to systematically review the available literature on the ethnobotanical, phytochemical, and pharmacological properties of R . hirtellus , thereby providing a foundation for future pharmacological and experimental research. Materials and Methods: A comprehensive literature search was conducted using databases such as Google Scholar and PubMed to identify studies related to the ethnobotanical, phytochemical, and pharmacological aspects of R . hirtellus . The review focused on its traditional uses, bioactive compounds, and experimentally validated biological activities. Results: R . hirtellus contains various phytochemicals, including flavonoids, steroids, glycosides, quinones, lactones, and lignified fibers. It exhibits diverse pharmacological activities, including antioxidant, antidiabetic, antibacterial, antifungal, anthelmintic, antiaging, antigout, anti‐irritant, and wound healing properties. In addition, it is used as livestock feed, a cooling agent, and for treating reproductive disorders. Preliminary evidence suggests its potential for anticancer, anti‐inflammatory, neuroprotective, and antiasthmatic effects, which remain underexplored. Conclusion: This review consolidates the traditional and pharmacological knowledge of R . hirtellus , highlighting its biomedical potential. Further computational and experimental studies are warranted to validate its therapeutic properties and explore its unexplored pharmacological activities.
- Open Access
- 2 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0326991
Phytochemical composition and bioactivity of Debregeasia saeneb leaves: Insights into anti-diabetic and antioxidant properties
Medicinal plants are an essential reservoir of natural compounds with diverse pharmacological properties. This study focuses on Debregeasia saeneb, (Forsk.) Hepper & J.R.I.Wood a relatively unexplored plant recognized for its traditional medicinal uses. The research aims to identify and analyze the phytochemical composition of D. saeneb (Forsk.) Hepper & J.R.I.Wood leaves, as well as evaluating their antioxidant and antidiabetic potential. This study systematically identified and analyzed the phytochemical constituents of D. saeneb (Forsk.) Hepper & J.R.I.Wood leaves utilizing Gas Chromatography-Mass Spectrometry (GC-MS), alongside both quantitative and qualitative assays. The biological activities were assessed through radical scavenging assays, specifically DPPH (1,1-di-phenyl-2-picrylhydrazyl), ABTS (2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)), and α-amylase inhibitory assays, which have been largely underexplored across various solvents. The GC-MS analysis revealed a diverse range of compounds, with ethyl acetate extracts containing six compounds, chloroform extracts containing seven, and n-hexane extracts containing three distinct compounds. Further qualitative assessments confirmed the presence of glycosides, leucoanthocyanins, quinones, lignins, carbohydrates, terpenoids, anthraquinones, and phlobatannins in the extracts of D. saeneb (Forsk.) Hepper & J.R.I.Wood. Quantitative analyses established the total phenolic, tannin, and flavonoid contents, revealing a positive correlation among the different extracts. Specifically, the total flavonoid (TF) content in the standard ranged from 0.34 to 1.189 µg/mL, while in methanol extracts it ranged from 0.087 to 0.778 µg/mL, in ethyl acetate from 0.188 to 0.624 µg/mL, and in n-hexane from 0.03 to 0.44 µg/mL. The total tannin content (TTC) in the standard ranged from 0.462 to 2.359 µg/mL, with methanol extracts showing values from 0.016 to 0.048 µg/mL, ethyl acetate from 0.0196 to 0.153 µg/mL, and n-hexane from 0.0012 to 0.134 µg/mL. The total phenolic content (TPC) in the standard ranged from 0.11 to 0.38 µg/mL, with methanol extracts ranging from 0.042 to 0.267 µg/mL, ethyl acetate from 0.0275 to 0.487 µg/mL, and n-hexane from 0.001 to 0.348 µg/mL. In ethanol extracts, the radical scavenging capacity (RSC) ranged from 0.005 to 0.05 µg/mL, in methanol from 0.01 to 0.09 µg/mL, and in aqueous extracts from 0.005 to 0.035 µg/mL, while the standard RSC ranged from 0.5 to 4.5 µg/mL. The biological activity assays indicated that D. saeneb (Forsk.) Hepper & J.R.I.Wood extracts exhibited significant α-amylase inhibition, suggesting potential anti-diabetic properties. Furthermore, all extracts demonstrated radical scavenging activity in both ABTS and DPPH assays, with the methanol extract exhibiting the highest antioxidant activity. In conclusion, this research provides comprehensive insights into the phytochemical profile of D. saeneb (Forsk.) Hepper & J.R.I.Wood leaves and its potential therapeutic applications, including anti-diabetic and antioxidant effects, thereby warranting further investigation into molecular mechanisms, drug development, and health promotion.
- 2 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0326991
Open AccessPhytochemical composition and bioactivity of Debregeasia saeneb leaves: Insights into anti-diabetic and antioxidant properties
Medicinal plants are an essential reservoir of natural compounds with diverse pharmacological properties. This study focuses on Debregeasia saeneb, (Forsk.) Hepper & J.R.I.Wood a relatively unexplored plant recognized for its traditional medicinal uses. The research aims to identify and analyze the phytochemical composition of D. saeneb (Forsk.) Hepper & J.R.I.Wood leaves, as well as evaluating their antioxidant and antidiabetic potential. This study systematically identified and analyzed the phytochemical constituents of D. saeneb (Forsk.) Hepper & J.R.I.Wood leaves utilizing Gas Chromatography-Mass Spectrometry (GC-MS), alongside both quantitative and qualitative assays. The biological activities were assessed through radical scavenging assays, specifically DPPH (1,1-di-phenyl-2-picrylhydrazyl), ABTS (2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)), and α-amylase inhibitory assays, which have been largely underexplored across various solvents. The GC-MS analysis revealed a diverse range of compounds, with ethyl acetate extracts containing six compounds, chloroform extracts containing seven, and n-hexane extracts containing three distinct compounds. Further qualitative assessments confirmed the presence of glycosides, leucoanthocyanins, quinones, lignins, carbohydrates, terpenoids, anthraquinones, and phlobatannins in the extracts of D. saeneb (Forsk.) Hepper & J.R.I.Wood. Quantitative analyses established the total phenolic, tannin, and flavonoid contents, revealing a positive correlation among the different extracts. Specifically, the total flavonoid (TF) content in the standard ranged from 0.34 to 1.189 µg/mL, while in methanol extracts it ranged from 0.087 to 0.778 µg/mL, in ethyl acetate from 0.188 to 0.624 µg/mL, and in n-hexane from 0.03 to 0.44 µg/mL. The total tannin content (TTC) in the standard ranged from 0.462 to 2.359 µg/mL, with methanol extracts showing values from 0.016 to 0.048 µg/mL, ethyl acetate from 0.0196 to 0.153 µg/mL, and n-hexane from 0.0012 to 0.134 µg/mL. The total phenolic content (TPC) in the standard ranged from 0.11 to 0.38 µg/mL, with methanol extracts ranging from 0.042 to 0.267 µg/mL, ethyl acetate from 0.0275 to 0.487 µg/mL, and n-hexane from 0.001 to 0.348 µg/mL. In ethanol extracts, the radical scavenging capacity (RSC) ranged from 0.005 to 0.05 µg/mL, in methanol from 0.01 to 0.09 µg/mL, and in aqueous extracts from 0.005 to 0.035 µg/mL, while the standard RSC ranged from 0.5 to 4.5 µg/mL. The biological activity assays indicated that D. saeneb (Forsk.) Hepper & J.R.I.Wood extracts exhibited significant α-amylase inhibition, suggesting potential anti-diabetic properties. Furthermore, all extracts demonstrated radical scavenging activity in both ABTS and DPPH assays, with the methanol extract exhibiting the highest antioxidant activity. In conclusion, this research provides comprehensive insights into the phytochemical profile of D. saeneb (Forsk.) Hepper & J.R.I.Wood leaves and its potential therapeutic applications, including anti-diabetic and antioxidant effects, thereby warranting further investigation into molecular mechanisms, drug development, and health promotion.
- Open Access
- 8 May 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (20) , 21805-21821
Phytochemicals, Antioxidant, and Antidiabetic Effects of Ranunculus hirtellus Aerial Parts and Roots: Methanol and Aqueous Extracts
Ranunculus hirtellus, also known as crowfoot (buttercup), has a rich tradition of use in various biological contexts. While antibacterial studies on extracts from this plant have been conducted, the phytochemical composition, antioxidant properties, and antidiabetic effects remain unexplored. In this study, the phytochemical, antioxidant, and antidiabetic effects of its methanol and aqueous extracts were investigated. Our approach involved gas chromatography-mass spectrometry (GC/MS), alongside quantitative and qualitative methods, for phytochemical profiles. Additionally, concerning biological activities, the antioxidant effect was assessed through 2, 2-diphenyl-pieryl hydrazyl (DPPH) and 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulfonate) (ABTS) assays, while the antidiabetic effect was examined through the α-amylase inhibitory assay. The chloroform, ethyl acetate, and n-hexane extracts of R. hirtellus revealed the presence of 14 distinct compounds. In the methanol extract, sterols, quinones, glycosides, lactones, lignin, and flavonoids were identified. The aqueous extract contained sterols, alkaloids, glycosides, triterpenes, terpenoids, quinones, leucoanthocyanins, and lactones. The total flavonoid content (TFC), total phenolic content (TPC), total tannin content (TTC), and reducing sugar content (RDC) were determined in plant extracts, and a linear relationship was found between these parameters. Additionally, the TTC, TPC, and TFC values for both extracts hovered around 0.3786, 0.0476, and 0.1864 μg/mL, respectively, across all plant concentrations, while RDC ranged from 0.9336 to 1.0119 μg/mL in all four extracts. In vitro assays demonstrated dose-dependent antidiabetic activity in both methanolic and aqueous extracts by inhibiting α-amylase. Furthermore, the antioxidant activity observed in the DPPH assay was greater in the aqueous extract compared with the methanolic extract. In addition, the ethyl acetate extract exhibited the highest inhibition among chloroform and n-hexane in the ABTS assay. The results suggest that R. hirtellus can be a potential source of natural antioxidants and antidiabetic agents, and further studies are warranted to investigate the underlying mechanisms of its therapeutic effects.
- 8 May 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (20) , 21805-21821
Open AccessPhytochemicals, Antioxidant, and Antidiabetic Effects of Ranunculus hirtellus Aerial Parts and Roots: Methanol and Aqueous Extracts
Ranunculus hirtellus, also known as crowfoot (buttercup), has a rich tradition of use in various biological contexts. While antibacterial studies on extracts from this plant have been conducted, the phytochemical composition, antioxidant properties, and antidiabetic effects remain unexplored. In this study, the phytochemical, antioxidant, and antidiabetic effects of its methanol and aqueous extracts were investigated. Our approach involved gas chromatography-mass spectrometry (GC/MS), alongside quantitative and qualitative methods, for phytochemical profiles. Additionally, concerning biological activities, the antioxidant effect was assessed through 2, 2-diphenyl-pieryl hydrazyl (DPPH) and 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulfonate) (ABTS) assays, while the antidiabetic effect was examined through the α-amylase inhibitory assay. The chloroform, ethyl acetate, and n-hexane extracts of R. hirtellus revealed the presence of 14 distinct compounds. In the methanol extract, sterols, quinones, glycosides, lactones, lignin, and flavonoids were identified. The aqueous extract contained sterols, alkaloids, glycosides, triterpenes, terpenoids, quinones, leucoanthocyanins, and lactones. The total flavonoid content (TFC), total phenolic content (TPC), total tannin content (TTC), and reducing sugar content (RDC) were determined in plant extracts, and a linear relationship was found between these parameters. Additionally, the TTC, TPC, and TFC values for both extracts hovered around 0.3786, 0.0476, and 0.1864 μg/mL, respectively, across all plant concentrations, while RDC ranged from 0.9336 to 1.0119 μg/mL in all four extracts. In vitro assays demonstrated dose-dependent antidiabetic activity in both methanolic and aqueous extracts by inhibiting α-amylase. Furthermore, the antioxidant activity observed in the DPPH assay was greater in the aqueous extract compared with the methanolic extract. In addition, the ethyl acetate extract exhibited the highest inhibition among chloroform and n-hexane in the ABTS assay. The results suggest that R. hirtellus can be a potential source of natural antioxidants and antidiabetic agents, and further studies are warranted to investigate the underlying mechanisms of its therapeutic effects.
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Food Quality
- Vol. 2024 (1)
Phytochemical Profiling and Therapeutic Potential of Abelmoschus esculentus Fruit Extracts: Insights Into Antidiabetic Potential in In Vitro and In Vivo Experiments
Due to inadequate treatment, diabetes mellitus, which is characterized by hyperglycemia, is a global health challenge that requires creative management techniques. This study explores the therapeutic potential of Abelmoschus esculentus L. Moench fruit extracts in diabetes, offering an ample approach includes phytochemical analysis, qualitative and quantitative assessments, antidiabetic efficacy, antioxidant potential, and in vivo and in vitro investigations. Thin‐layer chromatography (TLC), high‐performance liquid chromatography (HPLC), and gas chromatography–mass spectrometry (GC–MS) were utilized to disclose the phytochemical profile of the fruit extracts, which indicated a diverse range of bioactive compounds. Four polyphenolic compounds including chlorogenic acid, quercetin, rutin, and morin were confirmed by HPLC fingerprinting, with rutin being the most prevalent. Qualitative analysis reveals the presence of carbohydrates, emodin, terpenoids, lignin, glycosides, and anthraquinones, while indicating the absence of amino acids, anthocyanins, phlobatannins, lactones, and leucoanthocyanins. Quantitative analysis reveals total phenolic, tannin, and flavonoid. In vitro assessments demonstrate the ability of the extracts to inhibit alpha amylase. Radical scavenging activities were evaluated through DPPH assay, underscoring their antioxidant capacity with high effect in methanol extracts. Additionally, the methanol extract decreased the blood glucose level of Type 2 diabetic mice. Notably, test samples stabilized blood glucose levels, reversed deviations in blood profile parameters, blood biochemistry, and regulated organ weight. Based on its antioxidant and antidiabetic effects, as well as positive effects on the physiology of Type 2 diabetic mice, A. esculentus emerges as an important nutraceutical vegetable. As an important nutraceutical vegetable, it holds promise for diabetes management. A. esculentus can be incorporated into dietary interventions for individuals with diabetes, harnessing its natural antioxidant and antidiabetic properties. Our findings validate the traditional use of A. esculentus in green therapeutics. In conclusion, A. esculentus emerges as a valuable ally in the fight against diabetes, bridging the gap between ancient wisdom and modern science. Further research and practical implementation are warranted to fully realize its potential.
- 1 January 2024
- Published by Wiley in Journal of Food Quality
- Vol. 2024 (1)
Open AccessPhytochemical Profiling and Therapeutic Potential of Abelmoschus esculentus Fruit Extracts: Insights Into Antidiabetic Potential in In Vitro and In Vivo Experiments
Due to inadequate treatment, diabetes mellitus, which is characterized by hyperglycemia, is a global health challenge that requires creative management techniques. This study explores the therapeutic potential of Abelmoschus esculentus L. Moench fruit extracts in diabetes, offering an ample approach includes phytochemical analysis, qualitative and quantitative assessments, antidiabetic efficacy, antioxidant potential, and in vivo and in vitro investigations. Thin‐layer chromatography (TLC), high‐performance liquid chromatography (HPLC), and gas chromatography–mass spectrometry (GC–MS) were utilized to disclose the phytochemical profile of the fruit extracts, which indicated a diverse range of bioactive compounds. Four polyphenolic compounds including chlorogenic acid, quercetin, rutin, and morin were confirmed by HPLC fingerprinting, with rutin being the most prevalent. Qualitative analysis reveals the presence of carbohydrates, emodin, terpenoids, lignin, glycosides, and anthraquinones, while indicating the absence of amino acids, anthocyanins, phlobatannins, lactones, and leucoanthocyanins. Quantitative analysis reveals total phenolic, tannin, and flavonoid. In vitro assessments demonstrate the ability of the extracts to inhibit alpha amylase. Radical scavenging activities were evaluated through DPPH assay, underscoring their antioxidant capacity with high effect in methanol extracts. Additionally, the methanol extract decreased the blood glucose level of Type 2 diabetic mice. Notably, test samples stabilized blood glucose levels, reversed deviations in blood profile parameters, blood biochemistry, and regulated organ weight. Based on its antioxidant and antidiabetic effects, as well as positive effects on the physiology of Type 2 diabetic mice, A. esculentus emerges as an important nutraceutical vegetable. As an important nutraceutical vegetable, it holds promise for diabetes management. A. esculentus can be incorporated into dietary interventions for individuals with diabetes, harnessing its natural antioxidant and antidiabetic properties. Our findings validate the traditional use of A. esculentus in green therapeutics. In conclusion, A. esculentus emerges as a valuable ally in the fight against diabetes, bridging the gap between ancient wisdom and modern science. Further research and practical implementation are warranted to fully realize its potential.
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Food Quality
- Vol. 2024 (1)
Berberis lycium: A Miracle Medicinal Plant with Multifaceted Health Benefits
Throughout history, medicinal plants have been used to treat different ailments. About 70 to 80% of the world population rely on medicinal plants for healthcare and some use it for income generation. The annual sale of medicinal plants increases over time. In plants, Berberis vulgaris f. lycium (Royle) Parsa (Berberis lycium), also called boxthoran barberry, Indian barberry, or Indian lyceum contains key alkaloids such as berberine, camptothecin, koumidine, salutaridine, luteanine, palmatine, and protopine. Significant steroidal compounds include sitosterol and B‐sitosterol. The plant is rich in flavonoids such as isorhamnetin, formononetin‐7‐O‐glucoside, and velutin and anthocyanins such as cyanidin‐3‐glucoside and delphinidin‐3‐glucoside. It also includes phenolic compounds such as chlorogenic acid, caffeic acid, vanillic acid, and quercetin. B. lycium possesses dual utility due to its delicious fruit and has high value with known history in treatment of different disease and use in folklore medicines. Ethnobotanical surveys reveal that the B. lycium is used to treat jaundice, hepatitis, typhoid, fever, tuberculosis disorders, eye lotion, chronic diarrhoea, tonic, skin diseases, blood purifier, piles, eye infections, gum problems, diabetes, and kidney problems. Experimental studies have demonstrated that the B. lycium possesses antibacterial, antihyperlipidaemia, antidiabetic, anticolitis/inflammatory, anticancer activities, antiviral activities, and anthelminthic activities. According to our literature survey, there is no review with a mechanistic summary on B. lycium; therefore, the current review is an effort to provide the available literature on B. lycium in summary form for future research.
- 1 January 2024
- Published by Wiley in Journal of Food Quality
- Vol. 2024 (1)
Open AccessBerberis lycium: A Miracle Medicinal Plant with Multifaceted Health Benefits
Throughout history, medicinal plants have been used to treat different ailments. About 70 to 80% of the world population rely on medicinal plants for healthcare and some use it for income generation. The annual sale of medicinal plants increases over time. In plants, Berberis vulgaris f. lycium (Royle) Parsa (Berberis lycium), also called boxthoran barberry, Indian barberry, or Indian lyceum contains key alkaloids such as berberine, camptothecin, koumidine, salutaridine, luteanine, palmatine, and protopine. Significant steroidal compounds include sitosterol and B‐sitosterol. The plant is rich in flavonoids such as isorhamnetin, formononetin‐7‐O‐glucoside, and velutin and anthocyanins such as cyanidin‐3‐glucoside and delphinidin‐3‐glucoside. It also includes phenolic compounds such as chlorogenic acid, caffeic acid, vanillic acid, and quercetin. B. lycium possesses dual utility due to its delicious fruit and has high value with known history in treatment of different disease and use in folklore medicines. Ethnobotanical surveys reveal that the B. lycium is used to treat jaundice, hepatitis, typhoid, fever, tuberculosis disorders, eye lotion, chronic diarrhoea, tonic, skin diseases, blood purifier, piles, eye infections, gum problems, diabetes, and kidney problems. Experimental studies have demonstrated that the B. lycium possesses antibacterial, antihyperlipidaemia, antidiabetic, anticolitis/inflammatory, anticancer activities, antiviral activities, and anthelminthic activities. According to our literature survey, there is no review with a mechanistic summary on B. lycium; therefore, the current review is an effort to provide the available literature on B. lycium in summary form for future research.
- Open Access
- 1 March 2021
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 14, 1821-1841
Natural Polyphyllins (I, II, D, VI, VII) Reverses Cancer Through Apoptosis, Autophagy, Mitophagy, Inflammation, and Necroptosis
Cancer is the second leading cause of mortality worldwide. Conventional therapies, including surgery, radiation, and chemotherapy, have limited success because of secondary resistance. Therefore, safe, non-resistant, less toxic, and convenient drugs are urgently required. Natural products (NPs), primarily sourced from medicinal plants, are ideal for cancer treatment because of their low toxicity and high success. NPs cure cancer by regulating different pathways, such as PI3K/AKT/mTOR, ER stress, JNK, Wnt, STAT3, MAPKs, NF-kB, MEK-ERK, inflammation, oxidative stress, apoptosis, autophagy, mitophagy, and necroptosis. Among the NPs, steroid saponins, including polyphyllins (I, II, D, VI, and VII), have potent pharmacological, analgesic, and anticancer activities for the induction of cytotoxicity. Recent research has demonstrated that polyphyllins (PPs) possess potent effects against different cancers through apoptosis, autophagy, inflammation, and necroptosis. This review summarizes the available studies on PPs against cancer to provide a basis for future research.
- 1 March 2021
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 14, 1821-1841
Open AccessNatural Polyphyllins (I, II, D, VI, VII) Reverses Cancer Through Apoptosis, Autophagy, Mitophagy, Inflammation, and Necroptosis
Cancer is the second leading cause of mortality worldwide. Conventional therapies, including surgery, radiation, and chemotherapy, have limited success because of secondary resistance. Therefore, safe, non-resistant, less toxic, and convenient drugs are urgently required. Natural products (NPs), primarily sourced from medicinal plants, are ideal for cancer treatment because of their low toxicity and high success. NPs cure cancer by regulating different pathways, such as PI3K/AKT/mTOR, ER stress, JNK, Wnt, STAT3, MAPKs, NF-kB, MEK-ERK, inflammation, oxidative stress, apoptosis, autophagy, mitophagy, and necroptosis. Among the NPs, steroid saponins, including polyphyllins (I, II, D, VI, and VII), have potent pharmacological, analgesic, and anticancer activities for the induction of cytotoxicity. Recent research has demonstrated that polyphyllins (PPs) possess potent effects against different cancers through apoptosis, autophagy, inflammation, and necroptosis. This review summarizes the available studies on PPs against cancer to provide a basis for future research.
- 20 December 2020
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 97 (4) , 914-929
Molecular mechanisms of anticancer activities of polyphyllin VII
Cancer is the leading cause of mortality in the world. The major therapies for cancer treatment are chemotherapy, surgery, and radiation therapy. All these therapies expensive, toxic and show resistance. The plant‐derived compounds are considered safe, cost‐effective and target cancer through different pathways. In these pathways include oxidative stress, mitochondrial dependent and independent, STAT3, NF‐kB, MAPKs, cell cycle, and autophagy pathways. One of the new plants derived compounds is Polyphyllin VII (PPVII), which target cancer through different molecular mechanisms. In literature, there is a review gap of studies on PPVII; therefore in the current review, we summarized the available studies on PPVII to provide a base for future research.
- 20 December 2020
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 97 (4) , 914-929
Molecular mechanisms of anticancer activities of polyphyllin VII
Cancer is the leading cause of mortality in the world. The major therapies for cancer treatment are chemotherapy, surgery, and radiation therapy. All these therapies expensive, toxic and show resistance. The plant‐derived compounds are considered safe, cost‐effective and target cancer through different pathways. In these pathways include oxidative stress, mitochondrial dependent and independent, STAT3, NF‐kB, MAPKs, cell cycle, and autophagy pathways. One of the new plants derived compounds is Polyphyllin VII (PPVII), which target cancer through different molecular mechanisms. In literature, there is a review gap of studies on PPVII; therefore in the current review, we summarized the available studies on PPVII to provide a base for future research.
- 11 August 2020
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 97 (2) , 266-272
Alantolactone induces apoptosis in THP‐1 cells through STAT3, survivin inhibition, and intrinsic apoptosis pathway
Cancer is the second foremost cause of mortality in the world, and THP‐1 cells play an important role in cancer progression. Alantolactone (ALT), a sesquiterpene lactone compound derived from Inula helenium, has a number of biological activities including antibacterial, antifungal, and anticancer. The current study was conducted to investigate the effects of ALT on THP‐1 cells and its underlying molecular mechanisms. THP‐1 cells were cultured and treated with ALT (20, 40 µM) for 12 hr, and 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide, cell morphology, live/dead, and apoptosis assays were performed. The gene expressions at the protein level were checked through Western blot. Results show that ALT decreased cell viability and increased cell death and apoptosis. We found that ALT inhibited STAT3 and survivin expression. Furthermore, ALT induced mitochondrial‐dependent apoptosis through a decrease in B‐cell lymphoma‐2 (Bcl‐2) and Bcl‐xL and increase in Bax expression, resulting in the release of cytochrome c (Cyt‐c) from mitochondria. Cyt‐c release from mitochondria further increased cleaved (cl) caspase‐3 and cl‐PARP expression and led the cells to apoptosis. Therefore, ALT might be a good therapy for the progression due to THP‐1 cells.
- 11 August 2020
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 97 (2) , 266-272
Alantolactone induces apoptosis in THP‐1 cells through STAT3, survivin inhibition, and intrinsic apoptosis pathway
Cancer is the second foremost cause of mortality in the world, and THP‐1 cells play an important role in cancer progression. Alantolactone (ALT), a sesquiterpene lactone compound derived from Inula helenium, has a number of biological activities including antibacterial, antifungal, and anticancer. The current study was conducted to investigate the effects of ALT on THP‐1 cells and its underlying molecular mechanisms. THP‐1 cells were cultured and treated with ALT (20, 40 µM) for 12 hr, and 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide, cell morphology, live/dead, and apoptosis assays were performed. The gene expressions at the protein level were checked through Western blot. Results show that ALT decreased cell viability and increased cell death and apoptosis. We found that ALT inhibited STAT3 and survivin expression. Furthermore, ALT induced mitochondrial‐dependent apoptosis through a decrease in B‐cell lymphoma‐2 (Bcl‐2) and Bcl‐xL and increase in Bax expression, resulting in the release of cytochrome c (Cyt‐c) from mitochondria. Cyt‐c release from mitochondria further increased cleaved (cl) caspase‐3 and cl‐PARP expression and led the cells to apoptosis. Therefore, ALT might be a good therapy for the progression due to THP‐1 cells.
- Open Access
- 1 June 2020
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 13, 5207-5222
β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways
Background: The most common chemotherapeutic drug for triple-negative breast cancer (TNBC) treatment is 5-fluorouracil (5-FU), but its therapeutic index is low due to its toxicity. β-Elemene (ELE) possesses antitumor activity against different cancers, but it has never been used in combination with 5-FU to improve its chemotherapeutic effect against TNBC. Materials and Methods: We treated MDA-MB-231 and BT549 cells of TNBC with ELE alone, 5-FU alone, or their combination to investigate their treatment effects on cell viability, proliferation, migration, invasion, and colony formation. We verified the molecular mechanisms of our results through confocal immunofluorescence, immunohistochemistry, and Western blot analysis in vitro and in vivo. Results: Our result revealed that ELE enhanced the 5-FU effect against cell viability, proliferation, migration, invasion, and colony formation through different mechanisms in MDA-MB-231 and BT549 cell lines. In molecular mechanisms, ELE and 5-FU in combination enhances apoptosis in both cell lines through Bl-2 family protein and caspase cascade modulation, thereby inhibiting NF-kB pathway through IKKβ, IKKα, and p65 downregulation in the cytoplasm and p50 and p65 downregulation in the nucleus. ELE and 5-FU in combination regulated the PI3K/AKT pathway through p-AKT, P-85, p110r, p-PDK1, and p110a protein and RAF-MEK-ERK pathway inhibition through the p-c-raf and p-ERK downregulation. The PI3K inhibitor LY294002 or RAF-MEK-ERK inhibitor U0126 in combination with ELE and 5-FU decreased cell viability in both cell lines significantly, thereby showing the involvement of these pathways in cell apoptosis. In mouse xenograft model, ELE and 5-FU in combination inhibited the tumor growth and modulated its molecular markers. Conclusion: The conclusion obtained, considering that the results suggest that the combination may be important specifically in the treatment of TNBC.
- 1 June 2020
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 13, 5207-5222
Open Accessβ-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways
Background: The most common chemotherapeutic drug for triple-negative breast cancer (TNBC) treatment is 5-fluorouracil (5-FU), but its therapeutic index is low due to its toxicity. β-Elemene (ELE) possesses antitumor activity against different cancers, but it has never been used in combination with 5-FU to improve its chemotherapeutic effect against TNBC. Materials and Methods: We treated MDA-MB-231 and BT549 cells of TNBC with ELE alone, 5-FU alone, or their combination to investigate their treatment effects on cell viability, proliferation, migration, invasion, and colony formation. We verified the molecular mechanisms of our results through confocal immunofluorescence, immunohistochemistry, and Western blot analysis in vitro and in vivo. Results: Our result revealed that ELE enhanced the 5-FU effect against cell viability, proliferation, migration, invasion, and colony formation through different mechanisms in MDA-MB-231 and BT549 cell lines. In molecular mechanisms, ELE and 5-FU in combination enhances apoptosis in both cell lines through Bl-2 family protein and caspase cascade modulation, thereby inhibiting NF-kB pathway through IKKβ, IKKα, and p65 downregulation in the cytoplasm and p50 and p65 downregulation in the nucleus. ELE and 5-FU in combination regulated the PI3K/AKT pathway through p-AKT, P-85, p110r, p-PDK1, and p110a protein and RAF-MEK-ERK pathway inhibition through the p-c-raf and p-ERK downregulation. The PI3K inhibitor LY294002 or RAF-MEK-ERK inhibitor U0126 in combination with ELE and 5-FU decreased cell viability in both cell lines significantly, thereby showing the involvement of these pathways in cell apoptosis. In mouse xenograft model, ELE and 5-FU in combination inhibited the tumor growth and modulated its molecular markers. Conclusion: The conclusion obtained, considering that the results suggest that the combination may be important specifically in the treatment of TNBC.
- 5 February 2020
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 95 (4) , 427-434
SANTAMARINE: Mechanistic studies on multiple diseases
Medicinal plants are vital sources of modern and traditional Chinese medicines. Sesquiterpene lactones (SLs) consist of a large group of plant secondary metabolites and belong to C15 terpenoid group. SLs have shown various biological activities including antitumor and anti‐inflammatory activities. Santamarine (STM), C15H20O3, is a kind of sesquiterpene lactone, whose molecular weight is 248.322 g/mol. Santamarine has been isolated from several plants species and has shown eminent biological activities, such as anticancer activity and anti‐inflammatory activity. In this mini‐review, we summarize the studies on the effects and the mechanisms of STM, and explore the avenues of application.
- 5 February 2020
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 95 (4) , 427-434
SANTAMARINE: Mechanistic studies on multiple diseases
Medicinal plants are vital sources of modern and traditional Chinese medicines. Sesquiterpene lactones (SLs) consist of a large group of plant secondary metabolites and belong to C15 terpenoid group. SLs have shown various biological activities including antitumor and anti‐inflammatory activities. Santamarine (STM), C15H20O3, is a kind of sesquiterpene lactone, whose molecular weight is 248.322 g/mol. Santamarine has been isolated from several plants species and has shown eminent biological activities, such as anticancer activity and anti‐inflammatory activity. In this mini‐review, we summarize the studies on the effects and the mechanisms of STM, and explore the avenues of application.